H1, a New York-based provider of live data insights to help fight diseases, raised $6m in funding.
The investor was Shore Group.
The company intends to use the funds to accelerate growth.
Led by Ariel Katz, H1 provides healthcare organizations with live data insights to help fight diseases. The company’s platform provides real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, enabling healthcare and life sciences companies to make scientific decisions. Working with medical affairs and strategy teams who span all phases of the development lifecycle, H1 provides the complete picture of institutions, experts, scholarly content, markets, competitors and new opportunities through research grounded in actual data and clinical findings from any public clinical and scholarly database anywhere in the world.
The company offers:
H1 Ada: Comprehensive and up-to-date records of the people and organizations driving medicine,
H1 Curie: Information and analytics around thought leaders and their accomplishments – all in one place, and
H1 DaVinci (launched Sept 2018): Strategy-as-a-service offering that helps strategic planning team unlock more valuable opportunities.